Robert A. Eckert - 23 May 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Reporting relationship: Director
Issuer ticker: AMGN
Reported as of: 23 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2025, 20:59:47 UTC
Prior SEC filing: 12 May 2025
Next SEC filing: 12 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert A. Eckert

Key filing fact

Robert A. Eckert filed Form 4 for AMGEN INC (AMGN) on 28 May 2025.

Key facts

This page summarizes Robert A. Eckert's Form 4 filing for AMGEN INC (AMGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 May 2025, 20:59.

Change

Previous filing in this sequence was filed on 12 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001194256 Primary reporting owner

ECKERT ROBERT

Relationship: Director
Address: ONE AMGEN CENTER DRIVE, THOUSAND OAKS
Signature: /s/ Robert A. Eckert
Signature date: 23 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMGN transaction

Common Stock

Award

Transaction value: $0
Shares: +809
Change %: +3.3%
Price: $0.000000
Shares after: 25,027
Date: 23 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

Footnote F2

These shares include 3,384 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.